HHGA
ALXN

Halbert Hargrove Global Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,200
Closed -$229K – 99
2015
Q4 		$229K Buy
+1,200
New +$210K 0.1% 88
2015
Q3 		– Sell
-2,518
Closed -$455K – 166
2015
Q2 		$455K Buy
2,518
+300
+14% +$51.8K 0.11% 97
2015
Q1 		$384K Buy
2,218
+673
+44% +$122K 0.12% 120
2014
Q4 		$286K Sell
1,545
-18
-1% -$3.33K 0.14% 94
2014
Q3 		$259K Buy
+1,563
New +$257K 0.07% 112
2014
Q2 		– Sell
-2,930
Closed -$446K – 143
2014
Q1 		$446K Sell
2,930
-361
-11% -$57.4K 0.14% 49
2013
Q4 		$437K Sell
3,291
-353
-10% -$42.4K 0.14% 51
2013
Q3 		$423K Sell
3,644
-252
-6% -$27.6K 0.14% 50
2013
Q2 		$359K Buy
+3,896
New +$375K 0.13% 64

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return